Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Anti-neoplastic glucuronide prodrug treatment of human tumor cells targeted with a monoclonal antibody-enzyme conjugate.

× No keyword cloud information.

7 in total

1. Analysis of antibody-enzyme conjugate clearance by investigation of prodrug and active drug in an ADEPT clinical study.

Authors: C J Springer; G K Poon; S K Sharma; K D Bagshawe
Journal: Cell Biophys Date: 1994

Review 2. Antibody-directed enzyme prodrug therapy.

Authors: K D Bagshawe
Journal: Clin Pharmacokinet Date: 1994-11 Impact factor: 6.447

3. Amide-based prodrugs of spermidine-bridged dinuclear platinum. Synthesis, DNA binding, and biological activity.

Authors: Alexander Hegmans; Jana Kasparkova; Oldrich Vrana; Lloyd R Kelland; Viktor Brabec; Nicholas P Farrell
Journal: J Med Chem Date: 2008-03-14 Impact factor: 7.446

4. Bystander killing of tumour cells by antibody-targeted enzymatic activation of a glucuronide prodrug.

Authors: T L Cheng; S L Wei; B M Chen; J W Chern; M F Wu; P W Liu; S R Roffler
Journal: Br J Cancer Date: 1999-03 Impact factor: 7.640

5. ATIQCTPC: a nanomedicine capable of targeting tumor and blocking thrombosis in vivo.

Authors: Xinyi Xu; Yuji Wang; Jianhui Wu; Xi Hu; Haimei Zhu; Xiaoyi Zhang; Yaonan Wang; Lin Gui; Ming Zhao; Shiqi Peng
Journal: Int J Nanomedicine Date: 2017-06-13

6. A monoclonal antibody-beta-glucuronidase conjugate as activator of the prodrug epirubicin-glucuronide for specific treatment of cancer.

Authors: H J Haisma; E Boven; M van Muijen; J de Jong; W J van der Vijgh; H M Pinedo
Journal: Br J Cancer Date: 1992-09 Impact factor: 7.640

Review 7. Targeting enzymes for cancer therapy: old enzymes in new roles.

Authors: M P Deonarain; A A Epenetos
Journal: Br J Cancer Date: 1994-11 Impact factor: 7.640

7 in total